Dysregulation of the type 1 IGF receptor as a paradigm in tumor progression.
The Type 1 IGF receptor plays a critical role in cell progression. During normal ontogeny it is expressed by every proliferating cell, where it functions as a potent cell survival agent. Disruption of the Type 1 IGF receptor gene by homologous recombination results in severely growth retarded animals which invariably die at birth. Most importantly, fibroblasts derived from mice embryos lacking the receptor cannot be transformed by any of a number of oncogenes, indicating that the Type 1 IGF receptor has a crucial role in the transformation process. Consistently, the receptor displays potent mitogenic and antiapoptotic activities [corrected]. A number of transcription factors have been identified that control the expression of the IGF receptor promoter, thus stimulating cellular proliferation. On the other hand, certain tumour suppressors including p53 and WT1 were shown to repress the activity of the IGF receptor promoter. Mutant forms of these and other tumour suppressors are potentially impaired in their ability to suppress expression of the IGF receptor gene, thus helping to expand neoplastic populations.
Department of Clinical Biochemistry, Sackler School of Medicine, Tel Aviv University, Israel. hwerner@post.tau.ac.il
H
H
Werner
D000818:Animals; D017209:Apoptosis; D002453:Cell Cycle; D002470:Cell Survival; D018450:Disease Progression; D006801:Humans; D009369:Neoplasms / Q000473:pathology* / Q000503:physiopathology; D017526:Receptor, IGF Type 1 / Q000737:chemistry / Q000235:genetics* / Q000502:physiology*
D017526:Receptor, IGF Type 1